In partnership with Mount Sinai, Johns Hopkins, and other top research institutions, OneStep is proving that mobility data is the key to earlier disease detection and better patient outcomes
New York, NY — April 1, 2025 — OneStep, an innovator in digital healthcare, is redefining how mobility data is used in medical research, proving that gait is one of the most overlooked yet powerful vital signs. Once limited to specialized labs and expensive wearables, gait analysis is now more accessible, scalable and insightful than ever—all research participants have to do is slip their smartphone in their pocket and take a few steps. This breakthrough offers a win-win-win: patients gain insights into their mobility, clinicians receive real-time data to guide care and researchers gain real-world evidence to advance treatments. Leading research institutions are taking notice.
OneStep partners with the world’s top research institutions, including Mount Sinai, Johns Hopkins, Dana-Farber, NYU Langone, Central Michigan University, Hebrew SeniorLife, Tel Aviv University and more. Powered by AI and FDA-listed, OneStep’s platform does more than track one million steps per day, it interprets patterns, identifies risk factors and delivers real-time insights that help clinicians and researchers make data-driven decisions. By capturing subtle mobility changes, OneStep enables earlier intervention and personalized care. These partnerships span disciplines, from tracking Parkinson’s and monitoring blood cancer treatment to studying gait as a biomarker for ADHD and autism.
Over the past 15 years, hundreds of studies have established gait as a clinically valuable biomarker across musculoskeletal, neurological, oncological, cardiovascular and metabolic diseases. Despite this foundation, real-world impact has been slow, limited by in-clinic assessments, scarce gait labs, with just 25 in the U.S., and impractical wearables. OneStep removes these barriers. By enabling both passive and active assessment of spatial-temporal gait measures, its smartphone-based technology provides continuous, real-world insights into mobility–capturing fluctuations that traditional assessments miss. This shift bridges the gap between scientific discovery and real-world patient outcomes, aligning the speed of real-world impact with the speed of science.
“With every study, we’re proving that gait isn’t just a secondary metric – it’s a fundamental health indicator that can transform how we track, diagnose, and treat disease. By making gait analysis continuous, real-world and scalable, we’re unlocking insights that were previously out of reach” said Yuval Naveh, cofounder and chief scientific officer at OneStep.
Josh Raysman, a seasoned leader who has driven Pfizer’s global patient-centric digital innovations and now serves as an advisor to OneStep, said, “In previous roles, we were driven by the powerful idea that “the patient is waiting.” With OneStep, we take that a step further–the patient is also moving. Our technology translates movement into meaningful insights, driving real-world impact. By enabling earlier diagnosis and deeper understanding between visits, we empower patients to take control and help clinicians deliver more proactive care.”
With an expanding network of research partnerships across oncology, neurology, orthopedics and aging and growing recognition in the scientific community, OneStep is proving that every step tells a story–and those stories are shaping the future of healthcare.
Mobility is more than movement—it’s a vital sign. Learn more at www.onestep.co
About OneStep
OneStep is an AI-powered digital care platform that uses smartphone sensors to transform real-life movement into clinical insights, helping healthcare providers assess, treat, and monitor patients from anywhere. Gait (i.e. human motion) is a leading indicator of health, and by making gait analysis as simple as stepping on a bathroom scale, OneStep empowers clinicians with actionable data to improve mobility, reduce falls, and enhance patient engagement. Our FDA-listed technology eliminates the need for wearables, delivering lab-quality gait and motion
analysis in seconds.
With a focus on personalized, proactive care, OneStep serves rehabilitation providers, health systems, and medical device manufacturers, helping them optimize clinical decision-making, streamline operations, and increase revenue through Remote Therapeutic Monitoring (RTM). We’re committed to transforming gait into a vital sign and making healthcare more precise and connected, improving quality of life for millions.
Media Contact
Brook Terran
Evergreen & Oak for OneStep
[email protected]
336-269-7001
